Status:
COMPLETED
Effects of Betaserc on Vestibular Compensation in Patients Suffering From Disabling Meniere's Disease and Having Undergone Vestibular Neurotomy
Lead Sponsor:
Solvay Pharmaceuticals
Conditions:
Meniere's Disease
Eligibility:
All Genders
18-65 years
Phase:
PHASE4
Brief Summary
This study is to compare the effects of Betaserc 24mg and placebo on compensation of postural and locomotor deficits (static and dynamic posturography) after vestibular neurotomy in patients suffering...
Eligibility Criteria
Inclusion
- Patients who have undergone vestibular neurotomy for the treatment of disabling Menière's disease and who have confirmed vestibular areflexia
Exclusion
- Other peripheral vestibular disease than Menière's disease
- Central vestibular disease
- Neurological disease
- Contraindication to betahistine
- Pregnant or lactating women
Key Trial Info
Start Date :
January 1 2003
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT00160238
Start Date
January 1 2003
Last Update
December 22 2006
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Site 1
Marseille, France